IIT2022-05-Sankar-Believe

IIT2022-05-Sankar-Believe: Phase II Study of Bevacizumab in Combination with Chemoimmunotherapy and Maintenance Atezolizumab in Patients with Extensive Stage Small Cell Lung Cancer and Liver Metastases